Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BELLA OPBEVARING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   7.6% 5.4% 5.1% 9.8% 6.1% 6.5% 19.0% 19.0%   Credit score (0-100)   33 41 42 24 37 37 7 7   Credit rating   BB BBB BBB BB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   49 50 44 45 43 50 50 50   Gross profit   11.5 28.6 23.1 -0.5 18.1 29.5 0.0 0.0   EBITDA   11.5 28.6 23.1 -0.5 18.1 29.5 0.0 0.0   EBIT   9.2 26.3 20.8 -2.8 15.8 27.2 0.0 0.0   Pre-tax profit (PTP)   7.7 25.2 19.6 -3.2 15.8 26.8 0.0 0.0   Net earnings   5.4 19.6 15.3 -2.8 10.7 20.8 0.0 0.0   Pre-tax profit without non-rec. items   7.7 25.2 19.6 -3.2 15.8 26.8 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   270 268 266 263 261 259 0.0 0.0   Shareholders equity total   153 172 187 185 195 155 75.1 75.1   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   272 301 303 265 268 261 75.1 75.1   Net Debt   -1.9 -2.9 -4.5 -1.4 -6.9 -2.5 -75.1 -75.1     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   49 50 44 45 43 50 50 50   Net sales growth   2.7% 1.0% -11.9% 3.5% -5.5% 16.6% 0.0% 0.0%   Gross profit   11.5 28.6 23.1 -0.5 18.1 29.5 0.0 0.0   Gross profit growth   -59.4% 149.2% -19.1% 0.0% 0.0% 63.0% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   272 301 303 265 268 261 75 75   Balance sheet change%   -1.8% 10.4% 0.7% -12.5% 1.2% -2.5% -71.2% 0.0%   Added value   11.5 28.6 23.1 -0.5 18.1 29.5 0.0 0.0   Added value %   23.3% 57.4% 52.7% -1.0% 42.2% 59.0% 0.0% 0.0%   Investments   -5 -5 -5 -5 -5 -5 -259 0   Net sales trend   2.0 3.0 -1.0 1.0 -1.0 1.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   23.3% 57.4% 52.7% -1.0% 42.2% 59.0% 0.0% 0.0%   EBIT %   18.6% 52.8% 47.4% -6.1% 36.8% 54.4% 0.0% 0.0%   EBIT to gross profit (%)   79.8% 91.9% 90.0% 609.5% 87.2% 92.1% 0.0% 0.0%   Net Earnings %   10.9% 39.5% 35.0% -6.1% 24.9% 41.5% 0.0% 0.0%   Profit before depreciation and extraordinary items %   15.6% 44.1% 40.2% -1.0% 30.3% 46.2% 0.0% 0.0%   Pre tax profit less extraordinaries %   15.6% 50.6% 44.8% -7.1% 36.8% 53.6% 0.0% 0.0%   ROA %   3.3% 9.2% 6.9% -1.0% 5.9% 10.3% 0.0% 0.0%   ROI %   5.9% 15.5% 11.0% -1.4% 7.9% 14.6% 0.0% 0.0%   ROE %   3.6% 12.1% 8.5% -1.5% 5.6% 11.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   56.0% 57.3% 61.9% 69.7% 72.9% 59.4% 100.0% 100.0%   Relative indebtedness %   229.4% 242.0% 241.8% 157.2% 146.0% 189.4% 0.0% 0.0%   Relative net indebtedness %   225.6% 236.1% 231.5% 154.1% 129.8% 184.4% -150.3% -150.3%   Net int. bear. debt to EBITDA, %   -16.2% -10.2% -19.5% 310.1% -38.4% -8.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7,370.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0   Current Ratio   0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0   Cash and cash equivalent   1.9 2.9 4.5 1.4 6.9 2.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   3.8% 65.3% 84.4% 3.1% 16.2% 5.0% 150.3% 150.3%   Net working capital   -111.3 -88.0 -69.0 -70.0 -55.7 -92.2 0.0 0.0   Net working capital %   -225.6% -176.7% -157.4% -154.1% -129.8% -184.4% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0